Evaluation of the interaction between tumor growth factor-β and interferon type i pathways in patients with covid-19: focusing on ages 1 to 90 years

HIGHLIGHTS

• who: Mitra Abbasifard from the patientsThe Rafsanjan University of Medical Sciences ethics committee approved the study protocol (IR.RUMS. REC.1400.149). Informed consent was obtained from all subjects. Furthermore, informed consent was obtained from parents or legal guardians for people under , years of age to include in the study. Gene expression assays have published the research work: Evaluation of the interaction between tumor growth factor-u03b2 and interferon type I pathways in patients with COVID-19: focusing on ages 1 to 90 years, in the Journal: (JOURNAL)
• what: This study investigated the impact of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.